RESLIZUMAB
Total Payments
$126,122
Transactions
363
Doctors
220
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $126,122 | 363 | 220 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $58,675 | 14 | 46.5% |
| Food and Beverage | $34,849 | 241 | 27.6% |
| Travel and Lodging | $32,598 | 108 | 25.8% |
Top Doctors Receiving Payments for RESLIZUMAB — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Critical Care Medicine | Tracy, CA | $491.96 | 3 |
| , MD | Allergy & Immunology | Galveston, TX | $491.96 | 3 |
| , MD | Allergy & Immunology | Huntington Beach, CA | $491.96 | 3 |
| , M.D | Specialist | Birmingham, AL | $491.96 | 3 |
| , MD | Allergy & Immunology | New York, NY | $491.96 | 3 |
| , MD | Allergy & Immunology | Charlotte, NC | $491.96 | 3 |
| , MD | Allergy & Immunology | Winston Salem, NC | $478.49 | 2 |
| , MD | Allergy & Immunology | Sheboygan, WI | $478.49 | 2 |
| , M.D | Emergency Medicine | Rocky Mount, VA | $373.79 | 2 |
| , MD | Allergy & Immunology | Scottsdale, AZ | $364.08 | 1 |
| , D.O | Pediatric Allergy/Immunology | Largo, FL | $186.00 | 2 |
| , M.D | Internal Medicine | North Palm Beach, FL | $178.14 | 2 |
| , M.D | Allergy & Immunology | Daytona Beach, FL | $119.65 | 2 |
| , D.O | General Acute Care Hospital | Coos Bay, OR | $119.09 | 2 |
| , M.D | Pediatrics | Spokane, WA | $119.09 | 2 |
| , MD | Sleep Medicine | Little Rock, AR | $100.00 | 1 |
| , M.D | Allergy & Immunology | Birmingham, AL | $100.00 | 1 |
| , M.D | Internal Medicine | Gainesville, FL | $100.00 | 1 |
| , M.D | Critical Care Medicine | Atlanta, GA | $100.00 | 1 |
| , MD | Sleep Medicine | Louisville, KY | $100.00 | 1 |
| , MD | Internal Medicine | Washington, DC | $100.00 | 1 |
| , M.D | Critical Care Medicine | Durham, NC | $100.00 | 1 |
| , MD | Internal Medicine | Alexandria, LA | $100.00 | 1 |
| , MD | Pulmonary Disease | New York, NY | $100.00 | 1 |
| , M.D | Pulmonary Disease | Berwyn Heights, MD | $100.00 | 1 |
Ad
Manufacturing Companies
- Teva Pharmaceuticals USA, Inc. $126,122
Product Information
- Type Drug
- Total Payments $126,122
- Total Doctors 220
- Transactions 363
About RESLIZUMAB
RESLIZUMAB is a drug associated with $126,122 in payments to 220 healthcare providers, recorded across 363 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..
Payment data is available from 2017 to 2017. In 2017, $126,122 was paid across 363 transactions to 220 doctors.
The most common payment nature for RESLIZUMAB is "Consulting Fee" ($58,675, 46.5% of total).